X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (20) 20
humans (16) 16
male (14) 14
aged (12) 12
middle aged (12) 12
index medicus (11) 11
adult (10) 10
aged, 80 and over (9) 9
oncology (9) 9
animals (8) 8
treatment outcome (6) 6
tyrosine kinase inhibitor (6) 6
dexamethasone - pharmacology (5) 5
fetus - metabolism (5) 5
indoles - administration & dosage (5) 5
pyrroles - administration & dosage (5) 5
su11248 (5) 5
carcinoma, non-small-cell lung - drug therapy (4) 4
corticosterone - metabolism (4) 4
disease progression (4) 4
lung neoplasms - drug therapy (4) 4
mice (4) 4
neoplasm staging (4) 4
pregnancy (4) 4
therapy (4) 4
administration, oral (3) 3
age factors (3) 3
antineoplastic agents - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
antitumor-activity (3) 3
breast neoplasms - drug therapy (3) 3
chemotherapy (3) 3
dose-response relationship, drug (3) 3
drug administration schedule (3) 3
ecology (3) 3
education (3) 3
endothelial growth-factor (3) 3
factor receptor (3) 3
indoles - adverse effects (3) 3
leucine - metabolism (3) 3
multicenter (3) 3
placenta - metabolism (3) 3
pyrroles - adverse effects (3) 3
research (3) 3
saccharomyces cerevisiae - genetics (3) 3
safety (3) 3
sunitinib (3) 3
survival rate (3) 3
thymidine - metabolism (3) 3
tissue distribution (3) 3
uridine - metabolism (3) 3
young adult (3) 3
amino acid sequence (2) 2
analysis (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents, hormonal - adverse effects (2) 2
antineoplastic agents, hormonal - therapeutic use (2) 2
antineoplastic agents, phytogenic - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - pharmacokinetics (2) 2
area under curve (2) 2
aromatase inhibitors (2) 2
article (2) 2
audiologic rehabilitation (2) 2
audiology & speech-language pathology (2) 2
bevacizumab (2) 2
brain - metabolism (2) 2
breast neoplasms - pathology (2) 2
carcinoma (2) 2
carcinoma, non-small-cell lung - mortality (2) 2
cell cycle (2) 2
cell cycle proteins (2) 2
cell nucleus - metabolism (2) 2
cells (2) 2
cells, cultured (2) 2
coeliac disease (2) 2
cytoplasm - metabolism (2) 2
disease (2) 2
disease-free survival (2) 2
dna-binding proteins (2) 2
docetaxel (2) 2
double-blind method (2) 2
drug therapy, combination (2) 2
ecosystems (2) 2
erlotinib hydrochloride (2) 2
ex-arable fields (2) 2
fatigue - chemically induced (2) 2
follow-up studies (2) 2
food science & technology (2) 2
gene expression (2) 2
genes (2) 2
genetic complementation test (2) 2
gliadin (2) 2
gluten (2) 2
growth (2) 2
growth-factor (2) 2
immunohistochemistry (2) 2
in-vivo (2) 2
indoles - therapeutic use (2) 2
interpersonal relations (2) 2
land-use legacies (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2014, Volume 371, Issue 21, pp. 1963 - 1971
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2008, Volume 26, Issue 4, pp. 650 - 656
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2010, Volume 28, Issue 29, pp. 4513 - 4520
Purpose This open-label, phase I, dose-escalation study assessed the maximum-tolerated dose (MTD), safety, pharmacokinetics, and antitumor activity of... 
LUNG-CANCER | MULTICENTER | THERAPY | ONCOLOGY | COLORECTAL-CANCER | METASTATIC BREAST-CANCER | TYROSINE KINASE INHIBITOR | GROWTH-FACTOR | ANTITUMOR-ACTIVITY | RENAL-CELL CARCINOMA | SU11248 | Neoplasms - metabolism | Pyrroles - pharmacokinetics | Nausea - chemically induced | Area Under Curve | Capecitabine | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Metabolic Clearance Rate | Fatigue - chemically induced | Diarrhea - chemically induced | Indoles - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Deoxycytidine - pharmacokinetics | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Pyrroles - administration & dosage | Aged, 80 and over | Pyrroles - adverse effects | Adult | Deoxycytidine - adverse effects | Female | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Administration, Oral | Deoxycytidine - administration & dosage | Treatment Outcome | Neoplasms - drug therapy | Vomiting - chemically induced | Indoles - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Indoles - pharmacokinetics | Aged | Fluorouracil - pharmacokinetics | Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Original Reports | Faze
Journal Article
Current Microbiology, ISSN 0343-8651, 09/2010, Volume 66, Issue 4, pp. 669 - 680
Sunitinib in combination with docetaxel enhances antitumor activity in xenograft models of human breast and non-small cell lung cancer. We assessed the maximum... 
Sunitinib | Phase I | Solid tumors | NSCLC | Antiangiogenesis | Docetaxel | ADVANCED BREAST-CANCER | BEVACIZUMAB | ANTITUMOR-ACTIVITY | FACTOR RECEPTOR | SU11248 | CHEMOTHERAPY | CELL LUNG-CANCER | ONCOLOGY | TYROSINE KINASE INHIBITOR | PHARMACOLOGY & PHARMACY | III TRIAL | ENDOTHELIAL GROWTH-FACTOR | Area Under Curve | Humans | Middle Aged | Half-Life | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Indoles - administration & dosage | Dose-Response Relationship, Drug | Taxoids - therapeutic use | Angiogenesis Inhibitors - administration & dosage | Antineoplastic Agents, Phytogenic - administration & dosage | Antineoplastic Agents - adverse effects | Pyrroles - administration & dosage | Endpoint Determination | Angiogenesis Inhibitors - therapeutic use | Pyrroles - adverse effects | Adult | Female | Antineoplastic Agents, Phytogenic - therapeutic use | Drug Therapy, Combination | Pyrroles - therapeutic use | Angiogenesis Inhibitors - adverse effects | Taxoids - adverse effects | Antineoplastic Agents, Phytogenic - adverse effects | Neoplasms - drug therapy | Taxoids - administration & dosage | Indoles - adverse effects | Indoles - therapeutic use | Aged | Complications and side effects | Care and treatment | Analysis | Oncology, Experimental | Research | Lung cancer, Non-small cell | Cancer | Index Medicus | Original
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 09/2012, Volume 7, Issue 9, pp. 1406 - 1416
Journal Article
Journal Article
by Tazoe, Toshiki and Huie, J. Russell and Guandique, Cristian F and Ma, Xiaokui and Sacramento, Jeffrey A and Tanaka, Sakae and Bresnahan, Jacqueline C and Beattie, Michael S and Ogata, Toru and Ferguson, Adam R and Ruan, Yiwen and Chen, Chen and Frye, Christian Corbin and Sengelaub, Dale and Xiong, Wenhui and Xiong, Wenhui and Jin, Xiaoming and Xu, Xiao-Ming and Xu, Xiao-Ming and Daphalapurkar, Nitin and Knutsen, Andrew and Pham, Dzung L and Ramesh, K.T and Tallarida, Christopher and Razmpour, Roshanak and Razmpour, Roshanak and Lutton, Evan and Persidsky, Yuri and Rawls, Scott and Ramirez, Servio and Ford, Joni and Burnsides, Chris and Fenn, Ashley and Popovich, Phillip and Lifshitz, Jonathan and Lifshitz, Jonathan and Walker, Rohan and Eiferman, Daniel and Godbout, Jonathan and Tyburski, Ashley and Clark, Shannon and Elliott, Melanie and Wang, Jian and Liu, Yang and Badner, Anna and Dragas, Rachel and Siddiqui, Ahad and Forner, Stefania and Vawda, Reaz and Fehlings, Michael and Hovda, David and Prins, Mayumi and May, Hazel and Rowe, Rachel and Rowe, Rachel and Rumney, Benjamin and Johnson, Steven and Adelson, P. David and Lifshitz, Jonathan and Thomas, Theresa and Nielson, Jessica and Guandique, Cristian and Liu, Aiwen and Tovar, C. Amy and Young, Wise and Beattie, Michael and Bresnahan, Jacqueline and Bresnahan, Jacqueline and Ferguson, Adam and DePasquale, Erica and Dorsett, Christopher and Floyd, Candace L and McCullumsmith, Robert and Tyagi, Reeta and Dale, Jacob and Benton, Richard L and Tyagi, Suresh C and Hoying, James B and Lominadze, David and Browne, Kevin D and Wolf, John A and Smith, Douglas H and Duda, John E and Cullen, D. Kacy and Juengst, Shannon and Failla, Michelle and Failla, Michelle and Galang, Gary and Conley, Yvette and Arenth, Patricia and Arenth, Patricia and Wagner, Amy and Wagner, Amy and Cheng, Jeffrey P and Bondi, Corina O and Kline, Anthony E and Chapman, Sandra and Krawczyk, Daniel and Ellis, Monica and Marion, Sarah and ...
Journal of Neurotrauma, ISSN 0897-7151, 06/2015, Volume 32, Issue 12, pp. A-1 - A-152
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 08/2007, Volume 2, Issue 8, pp. S705 - S705
Journal Article
The Guardian (pre-1997 Fulltext), ISSN 0261-3077, 05/1993
KERRY STERLING had been living opposite the Hare and Hounds for six years when it came up for sale. The less appealing of two pubs in Matching Tye - a tiny... 
Newspaper Article
Leukemia & Lymphoma, ISSN 1042-8194, 1999, Volume 34, Issue 3-4, pp. 295 - 304
This study was performed to determine the clinical activity and safety of paclitaxel in the treatment of patients with refractory or relapsing aggressive... 
Taxol(paclitaxel) | refractory | non-Hodgkin's lymphoma
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.